The AD group showed a significant increase in hepatic IL-6, TNF-α, NF-κB levels, and Caspase-3 activity by 319.3, 270, 889.3, and 154.9%, respectively, compared to the control value. The gene discussed is TNF; the disease is Alzheimer disease.